UiPath (PATH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
22 May, 2026Board of directors and corporate governance
Passing of director Sivaramakichenane Somasegar on May 19, 2026, announced to shareholders.
Somasegar, previously a nominee for election, will no longer stand for election at the June 25, 2026 Annual Meeting.
Board size reduced to eliminate the vacancy, with only seven nominees now standing for election.
June Yang appointed to the Nominating and Corporate Governance Committee.
Voting matters and shareholder proposals
Votes cast for Somasegar will not be counted; prior votes for other nominees remain valid.
Shareholders who have not voted may do so by methods described in the Proxy Statement.
Partial view of Summaries dataset, powered by Quartr API
Latest events from UiPath
- First full-year GAAP profitability, 14% Q4 revenue growth, and new $500M buyback.PATH
Q4 20269 Jul 2026 - Q4 revenue up 5% YoY to $424M; FY26 guidance strong but cautious amid macro headwinds.PATH
Q4 20258 Jul 2026 - Q3 revenue up 16% YoY, first GAAP profit, strong ARR growth, and robust Q4 guidance.PATH
Q3 20268 Jul 2026 - Q3 revenue up 9% year-over-year, ARR up 17%, and non-GAAP net income reached $59.8M.PATH
Q3 20258 Jul 2026 - All proposals, including director elections and auditor ratification, were approved without dissent.PATH
AGM 202625 Jun 2026 - Revenue up 17% to $418.4M, first Q1 GAAP profit, and strong AI-driven growth.PATH
Q1 20274 Jun 2026 - Stabilized growth, GAAP profitability, and AI-driven innovation are fueling larger enterprise deals.PATH
46th Annual William Blair Growth Stock Conference2 Jun 2026 - Key votes include director elections, executive pay approval, and auditor ratification.PATH
Proxy filing12 May 2026 - Shareholders will vote on directors, executive pay, and auditor ratification at the June 2026 meeting.PATH
Proxy filing12 May 2026